Future Alzheimer’s Treatments Aim To Do More Than Clear Plaques From the Brain
Many researchers believe amyloid drugs alone can’t stop Alzheimer’s. “The field has been moving beyond amyloid for many years now,” says Malú Gámez Tansey, co-director of the Center for Translational Research in Neurodegenerative Disease at the University of Florida.
UF Neuroscientists Discover Biomarker With Potential To Aid Parkinson’s Diagnosis
University of Florida neuroscientists have developed a new assay, or test, to detect minute amounts of a protein called tyrosine hydroxylase in blood immune cells of Parkinson’s disease patients, a key finding to aid in the development of a blood test to help diagnose and guide treatment for the neurodegenerative disorder.
UF Investigators Earn Michael J. Fox Foundation Award
Investigators at UF’s Center for Translational Research in Neurodegenerative Disease, or CTRND, earned a one-year, $200,000 award from the Michael J. Fox Foundation’s Target Advancement Program to explore novel approaches to treat Parkinson’s disease. “We hope that this study will help us understand more about the role of CB2 in brain immune cells to remove […]